SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimates of the Lifetime Direct Costs of Treatment for Metastatic Breast Cancer
9 references·5 citing·33 second hop
Estimates of the Lifetime Direct Costs of Treatment for Metastatic Breast Cancer (2000)Estimates of the Lifetime Direct Costs of…Estimates of the lifetime costs of breast cancer treatment in Canada (2000)Estimates of the lifetime cos…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1997)Recommendations of the Panel …Cost of care for cancer in a health maintenance organization. (1997)Cost of care for cancer in a …Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care (1995)Stage, Age, Comorbidity, and …POHEM--a framework for understanding and modelling the health of human populations. (1994)POHEM--a framework for unders…Advanced breast cancer: use of resources and cost implications (1993)Advanced breast cancer: use o…Estimating the Treatment Costs of Breast and Lung Cancer (1991)Estimating the Treatment Cost…The Distinction Between Cost and Charges (1982)The Distinction Between Cost …Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review (2022)Economic and Humanistic Burde…Indirect costs associated with metastatic breast cancer (2013)Indirect costs associated wit…The economic burden of metastatic breast cancer: a U.S. managed care perspective (2012)The economic burden of metast…Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium (2008)Trastuzumab in early stage br…An economic evaluation of Herceptin® in adjuvant setting: the Breast Cancer International Research Group 006 trial (2005)An economic evaluation of Her…EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)The economic cost of illness revisited. (1976)The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. (1980)The economic burden of lung cancer and the associated costs of treatment failure in the United States (2005)Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003 (2011)Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. (1992)Cost-Effectiveness in Health and Medicine (1996)Economic foundations of cost-effectiveness analysis (1997)The burden of illness associated with hepatocellular carcinoma in the United States (2008)Global treatment costs of breast cancer by stage: A systematic review (2018)The Costs of Treating Breast Cancer in the US (2009)Delivering affordable cancer care in high-income countries (2011)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Cost-of-Illness Studies (1992)Breast Cancer Management (2003)Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer (2010)Health care costs associated with hepatocellular carcinoma: A population-based study (2013)Projections of Global Mortality and Burden of Disease from 2002 to 2030 (2006)System Dynamics Modeling for Public Health: Background and Opportunities (2006)Demographic perspectives on the rise of longevity (2021)Assessing the costs of healthcare technologies in clinical trials. (1999)Criteria for evaluating evidence on public health interventions (2002)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Clinical Economics (1989)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Cost of Care for Elderly Cancer Patients in the United States (2008)‘More than just money’– widening the understanding of the costs involved in cancer care (2001)Cost of managing women presenting with stage IV breast cancer in the United Kingdom (2004)The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)Patient Time Costs Associated With Cancer Care (2007)
this work references cited by second hop

References

  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,507 cited
  • 1982The Distinction Between Cost and Charges1,055 cited
  • 1995Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care344 cited
  • 1997Cost of care for cancer in a health maintenance organization.196 cited
  • 1997Recommendations of the Panel on Cost-Effectiveness in Health and Medicine191 cited
  • 2000Estimates of the lifetime costs of breast cancer treatment in Canada147 cited
  • 1991Estimating the Treatment Costs of Breast and Lung Cancer130 cited
  • 1994POHEM--a framework for understanding and modelling the health of human populations.86 cited
  • 1993Advanced breast cancer: use of resources and cost implications82 cited

Cited by

  • 2012The economic burden of metastatic breast cancer: a U.S. managed care perspective57 cited
  • 2013Indirect costs associated with metastatic breast cancer53 cited
  • 2008Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium51 cited
  • 2022Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review49 cited
  • 2005An economic evaluation of Herceptin® in adjuvant setting: the Breast Cancer International Research Group 006 trial

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

49 cited